BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3891223)

  • 1. Clinical tolerance test of a new polysulfone membrane.
    Piazolo P; Brech W
    Contrib Nephrol; 1985; 46():118-26. PubMed ID: 3891223
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodiafiltration using readily available equipment.
    Kohnle W; Sprenger K; Spohn B; Franz HE
    J Dial; 1979; 3(1):27-39. PubMed ID: 381340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cellulose triacetate dialyzer and polysulfone synthetic hemofilter for continuous venovenous hemofiltration in acute renal failure.
    Pichaiwong W; Leelahavanichkul A; Eiam-ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S65-72. PubMed ID: 17044456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta2-microglobulin and low-flux synthetic dialyzers.
    Klinkmann H; Buscaroli A; Stefoni S
    Artif Organs; 1998 Jul; 22(7):585-90. PubMed ID: 9684696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the effects of low dialysate flow rates on removal rates and clearance using high flux membranes.
    Park KI; Tomoyoshi T
    Blood Purif; 1997; 15(3):208-12. PubMed ID: 9262848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
    Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
    Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance of a new high-flux synthetic membrane.
    Hoenich NA; Stamp S
    Am J Kidney Dis; 2000 Aug; 36(2):345-52. PubMed ID: 10922313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis.
    Schaefer RM; Gilge U; Goehl H; Heidland A
    Blood Purif; 1990; 8(1):23-31. PubMed ID: 2198889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new polysulfone hemofilter for continuous renal replacement therapy.
    Floris M; Marchionna N; Clementi A; Kim JC; Cruz DN; Nalesso F; Zanella M; Garzotto F; de Cal M; Virzì GM; Brendolan A; Ronco C
    Blood Purif; 2011; 32(2):133-8. PubMed ID: 21654165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Handling of high-permeability DIAPES: practical considerations.
    Potier J
    Contrib Nephrol; 2003; (138):110-6. PubMed ID: 12463153
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintaining blood compartment volume in dialyzers reprocessed with peracetic acid maintains Kt/V but not beta2-microglobulin removal.
    Ouseph R; Smith BP; Ward RA
    Am J Kidney Dis; 1997 Oct; 30(4):501-6. PubMed ID: 9328364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C; Tognotti D; Caponi L; Paolicchi A
    BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of beta 2-microglobulin by hemodialysis and hemofiltration: a four year follow up.
    Schiffl H; D'Agostini B; Held E
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(5):1223-32. PubMed ID: 1457695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea-190H) to a standard high flux polysulfone dialyser membrane (FX-80) in the setting of extended hours haemodialysis.
    Kameshwar K; Damasiewicz MJ; Polkinghorne KR; Kerr PG
    Nephrology (Carlton); 2022 Jun; 27(6):494-500. PubMed ID: 35195932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
    Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
    ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.